Tsubota Laboratory Incorporated
4890.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10,084,669 | ¥8,898,550 | ¥20,408,700 | ¥19,215,162 |
| - Cash | ¥1,538,853 | ¥1,883,400 | ¥2,161,016 | ¥1,174,929 |
| + Debt | ¥90,380 | ¥116,900 | ¥139,340 | ¥223,820 |
| Enterprise Value | ¥8,636,196 | ¥7,132,050 | ¥18,387,024 | ¥18,264,053 |
| Revenue | ¥1,357,133 | ¥673,532 | ¥954,693 | ¥640,921 |
| % Growth | 101.5% | -29.5% | 49% | – |
| Gross Profit | ¥1,176,902 | ¥21,379 | ¥719,136 | ¥557,018 |
| % Margin | 86.7% | 3.2% | 75.3% | 86.9% |
| EBITDA | ¥310,891 | -¥602,597 | ¥184,187 | ¥241,069 |
| % Margin | 22.9% | -89.5% | 19.3% | 37.6% |
| Net Income | ¥205,766 | -¥641,317 | ¥90,181 | ¥153,319 |
| % Margin | 15.2% | -95.2% | 9.4% | 23.9% |
| EPS Diluted | 7.92 | -25.15 | 3.52 | 6.77 |
| % Growth | 131.5% | -814.5% | -48% | – |
| Operating Cash Flow | -¥317,754 | -¥301,350 | ¥28,491 | ¥654,914 |
| Capital Expenditures | -¥13,994 | -¥12,001 | -¥48,757 | -¥72,228 |
| Free Cash Flow | -¥331,748 | -¥313,351 | -¥20,266 | ¥582,686 |